Orthobiologics are substances derived from human bodies that facilitates healing of injuries caused due to various factors such as broken bones, injured muscles, and ligaments. The increased demand from end-users such as hospitals, adoption of point of care testing and product portfolio expansion are the factors that are expected to foster the growth of the North American orthobiologics market. However, high cost of procedures, stringent regulatory requirements and lack of sufficient clinical trials are the factors that may restrain the growth of the market.
The report segments the market on the basis of types, end-users and country. On the basis of types, the market is segmented into bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy and viscosupplementation. On the basis of end-users, the market is segmented into hospitals, point-of-care testing and other end-users. Based on country, the market is segmented into U.S., Canada and Mexico.
Key market players operating in this market are Biomet, Inc., Medtronic Plc, Integra Life Sciences Corporation, Stryker Corporation, Zimmer, Inc., Tornier, Inc., Nuvasive, Inc., Exactech, Inc., Globus Medical Inc. and Wright Medical Technology, Inc.
KEY BENEFITS FOR STAKEHOLDERS:
The report provides a comprehensive analysis of current & future market trends and emerging avenues for the growth of this market.
The report offers an overview of changing market dynamics in terms of fast turn-around analysis of stakeholders’ responses to recent industry policy changes and market trends.
The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
This report entails the detailed quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.
Recent developments in government policies on various segments is highlighted along with offering insight into the regulatory framework impacting the market.
The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
The report offers the competitive landscape scenario in terms of the strategies adopted by key industry players to consolidate their market presence.
KEY MARKET SEGMENTS:
North American Orthobiologics Market – By Types
Bone Graft Substitutes
Bone Growth Factors & Spinal Stimulation
Stem Cell Therapy
North American Orthobiologics Market – By End-Users
North American Orthobiologics Market – By Country
Key Company Profile
Integra Life Sciences Corporation
Stryker Corporation, Zimmer, Inc.
Globus Medical Inc.
Wright Medical Technology, Inc.